Development of Diagnosis-Treatment Algorithm for Crohn's Disease and Ulcerative Colitis... Published in SCI-Level International Journal

Hanbang Treatment for 67 Patients... Symptom Improvement in First 3 Months
Completion of Diagnostic Protocol and Treatment Algorithm through Korean Medicine Approach

[Asia Economy Reporter Jang Hyowon] A research team led by Dr. Lee Byunghee and Dr. Won Jiyoon from the Department of Meridian Medicine at Kyung Hee University has developed customized diagnostic and treatment methods for Crohn's disease and ulcerative colitis, which are classified as rare intractable diseases.

Lee Byung-hee (left), Won Ji-yoon, Ph.D. in Meridian Medicine, Kyung Hee University

Based on clinical data accumulated since 2007, Dr. Lee Byunghee and Dr. Won Jiyoon's team conducted research on a total of 67 patients with Crohn's disease and ulcerative colitis. The study revealed 22 symptoms and 5 pathological patterns, based on which the research team derived a Korean medicine diagnostic protocol and treatment algorithm.

Dr. Lee Byunghee stated, “Patients experienced more than a 50% reduction in symptoms within the first three months after Korean medicine treatment, and clinical remission was achieved by the end of the treatment,” adding, “Only three patients continued taking Western medicine after their symptoms disappeared, while all other patients discontinued the use of Western medicine.”

These research results were published in the June issue of the European Journal of Integrative Medicine, an SCI-level international academic journal.

Dr. Lee Byunghee, who conducts both research and treatment, is a Korean medicine doctor. As the director of Han Georeum Korean Medicine Clinic, he organized the algorithm based on cases and experience treating Crohn's disease and ulcerative colitis since 2007.

He discovered that Crohn's disease and ulcerative colitis are not simply intestinal diseases but systemic immune-related disorders, classified them according to Korean medicine, and created an algorithm based on these patterns to propose a treatment protocol.

Dr. Lee Byunghee continues to publish related papers while simultaneously treating patients. Because clinical cases from patient treatment are organized into papers, it was possible to classify symptoms, verify them, and develop a customized treatment algorithm.

Meanwhile, Crohn's disease and ulcerative colitis are autoimmune diseases characterized by unexplained inflammation in the small and large intestines. Inflammatory bowel disease (IBD) is still classified as a rare intractable disease in modern medicine because its causes and treatments have not yet been identified.

This content was produced with the assistance of AI translation services.